» Articles » PMID: 33681790

Moyamoya Vasculopathy in a Young Caucasian Woman with Significant Methamphetamine Use

Overview
Journal BMJ Neurol Open
Specialty Neurology
Date 2021 Mar 8
PMID 33681790
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Moyamoya is a rare cerebrovascular disorder seen predominantly in Asian populations. Methamphetamine use is a recognised cause of stroke in young people, but its pathophysiology is not fully understood. The incidence of moyamoya vasculopathy in methamphetamine-associated stroke is unknown due to a lack of sufficient data. We present a rare case of moyamoya syndrome in a young Caucasian woman with methamphetamine-associated stroke.

Case: A 31-year-old Caucasian woman presented with progressive right arm weakness, speech disturbance and seizures on a background of escalating methamphetamine use in the 9 months prior to admission. She did not have a personal or family history of stroke. MRI revealed both embolic and watershed infarcts in bilateral frontal regions and CT angiography showed development of new lenticulostriate collateral vessels. Digital subtraction angiography confirmed steno-occlusive disease of the bilateral anterior circulations and a 'puff of smoke' appearance.

Conclusion: In young patients who present with stroke with unclear aetiology, it is important to obtain a thorough substance use history. Moyamoya vasculopathy should be considered when evaluating the pathophysiology of stroke in young people.

Citing Articles

Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use.

Kim A, Sabbagh O, Sabbagh O, Abou-Jaoude M, Kitchens J J Vitreoretin Dis. 2025; :24741264241302870.

PMID: 39963690 PMC: 11830160. DOI: 10.1177/24741264241302870.

References
1.
Darke S, Lappin J, Kaye S, Duflou J . Clinical Characteristics of Fatal Methamphetamine-related Stroke: A National Study. J Forensic Sci. 2017; 63(3):735-739. DOI: 10.1111/1556-4029.13620. View

2.
Duan L, Wei L, Tian Y, Zhang Z, Hu P, Wei Q . Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. Stroke. 2017; 49(1):11-18. DOI: 10.1161/STROKEAHA.117.017430. View

3.
Fukui M . Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997; 99 Suppl 2:S238-40. View

4.
Kuroda S, Houkin K . Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008; 7(11):1056-66. DOI: 10.1016/S1474-4422(08)70240-0. View

5.
Lappin J, Darke S, Farrell M . Stroke and methamphetamine use in young adults: a review. J Neurol Neurosurg Psychiatry. 2017; 88(12):1079-1091. DOI: 10.1136/jnnp-2017-316071. View